Osaic Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10
Closed -$350 7629
2024
Q3
$350 Buy
+10
New +$424 ﹤0.01% 7077
2022
Q2
Sell
-4
Closed -$6K 7593
2022
Q1
$6K Buy
+4
New +$467 ﹤0.01% 6419

Other funds holding TNDM

Osaic Holdings's TNDM Position: Q1 2026 in Review

Osaic Holdings reduced its Tandem Diabetes Care (TNDM) stake by 1.1% in Q1 2026, selling an estimated $608 and leaving 2,588 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5227.

Osaic Holdings first reported a position in TNDM in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.1M in Q4 2021. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Osaic Holdings held 2,588 shares of Tandem Diabetes Care worth $49.6K as of Q1 2026.
  • Osaic Holdings sold 28 Tandem Diabetes Care shares in Q1 2026, an estimated $608.
  • Tandem Diabetes Care made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5227 holding.
  • Osaic Holdings first reported a position in Tandem Diabetes Care in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Tandem Diabetes Care position peaked at $2.1M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.